Systemic toxicity in early-stage mood disorders

Journal of Psychiatric Research

Volumn 45, Issue 10, 2011, Pages 1407-1409

  Magalhães, Pedro V S ^a   Jansen, Karen ^b   Pinheiro, Ricardo Tavares ^b   Klamt, Fábio ^c   Teixeira, Antonio Lucio ^d   Da Silva, Ricardo Azevedo ^a   Kapczinski, Flávio ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b CATHOLIC UNIVERSITY OF PELOTAS   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Bipolar disorder; Brain derived neurotrophic factor; Inflammation; Major depression; Neurotrophins; Oxidative damage; Systemic toxicity

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

BIPOLAR DISORDER; BIVARIATE ANALYSIS; CASE CONTROL STUDY; HUMAN; LETTER; LINEAR REGRESSION ANALYSIS; MAJOR DEPRESSION; MENTAL PATIENT; MOOD DISORDER; MULTIVARIATE ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; SAMPLE SIZE; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TOXICITY;

EID: 80053118102     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2011.05.008     Document Type: Letter

References (11)

1. Andreazza A.C., Kapczinski F., Kauer-Sant'Anna M., Walz J.C., Bond D.J., Goncalves C.A., et al. 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. Journal of Psychiatry & Neuroscience 2009, 34.
2. Berk M., Kapczinski F., Andreazza A.C., Dean O.M., Giorlando F., Maes M., et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neuroscience and Biobehavioral Reviews 2011, 35:804-817.
3. Goldstein B.I., Kemp D.E., Soczynska J.K., McIntyre R.S. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. Journal of Clinical Psychiatry 2009, 70:1078-1090.
4. Henderson A.R. The bootstrap: a technique for data-driven statistics. Using computer-intensive analyses to explore experimental data. Clinica Chimica Acta 2005, 359:1-26.
5. Henrique I., De Micheli D., Lacerda R., Lacerda L., Formigoni M. Validation of the Brazilian version of alcohol, smoking and substance involvement screening test (ASSIST). Revista da Associacao Medica Brasileira 2004, 50:199-206.
6. Jansen K., Ores L.da C., Cardoso T.de A., Lima R.da C., Souza L.D., Magalhaes P.V., et al. Prevalence of episodes of mania and hypomania and associated comorbidities among young adults. Journal of Affective Disorders 2011, 130:328-333.
7. Kapczinski F., Dal-Pizzol F., Teixeira A.L., Magalhaes P.V.S., Kauer-Sant'Anna M., Klamt F., et al. A systemic toxicity index developed to assess peripheral changes in mood episodes. Molecular Psychiatry 2010, 15:784-786.
8. Kapczinski F., Dal-Pizzol F., Teixeira A.L., Magalhaes P.V.S., Kauer-Sant'Anna M., Klamt F., et al. Peripheral biomarkers and illness activity in bipolar disorder. Journal of Psychiatric Research 2011, 45:156-161.
9. Kauer-Sant'Anna M., Kapczinski F., Andreazza A.C., Bond D.J., Lam R.W., Young L.T., et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. International Journal of Neuropsychopharmacology 2009, 12:447-458.
10. Pasco J.A., Jacka F.N., Williams L.J., Henry M.J., Nicholson G.C., Kotowicz M.A., et al. Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression. Psychotherapy and Psychosomatics 2010, 323-325. Switzerland.
11. Soreca I., Frank E., Kupfer D.J. The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis?. Depression and Anxiety 2009, 26:73-82.